E2SSB 5395
SignedSenate
Prior authorization/health
Making improvements to transparency and accountability in the prior authorization determination process.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill improves transparency and accountability in Washington’s prior authorization process by setting strict timelines for coverage decisions, limiting the use of artificial intelligence in denial decisions, requiring more detailed explanations for denials, and mandating electronic tools to streamline the process. It applies to all health plans, including those for public employees, Medicaid managed care, and commercial insurers.
- Sets strict time limits for prior authorization decisions: 3 calendar days for electronic standard requests, 1 calendar day for electronic expedited requests, and longer timelines for non-electronic requests.
- Prohibits artificial intelligence or algorithms from being the sole basis for denying, delaying, or modifying care — decisions must be made by licensed physicians or health professionals.
- Requires health plans and managed care organizations to use application programming interfaces (APIs) to automate prior authorization checks and submissions starting January 1, 2025 (for services) and January 1, 2027 (for prescription drugs).
- Mandates that prior authorization decisions include a unique identifier for the reviewer and the national provider ID, credentials, and specialty of the overseeing physician in all communications to patients and providers.
- Requires annual updates to clinical review criteria to ensure they are evidence-based and inclusive of racial, ethnic, gender, and underserved population considerations.
- Requires insurers and managed care organizations to report quarterly and annually to state agencies (Insurance Commissioner and Health Care Authority) on prior authorization volumes, approval/denial rates, and use of artificial intelligence tools.
Who is affected
- Health insurers and managed care organizations — Health plans, insurance carriers, and managed care organizations must comply with new transparency, timing, and accountability requirements for prior authorization decisions, including limitations on use of artificial intelligence and new reporting obligations.
- Health care providers — Providers (doctors, clinics, hospitals) must follow new rules about how quickly prior authorization decisions are made, receive more detailed explanations for denials, and gain access to automated tools to check authorization needs and submit requests.
- Health plan enrollees (patients) — Patients may experience faster decisions for needed care, clearer reasons for coverage denials, and more consistent access to services without delays caused by administrative barriers.
- State employees and retirees — Public employees, retirees, and their dependents enrolled in state-offered health plans will see improvements in prior authorization transparency and timeliness.
- Medicaid enrollees — Medicaid enrollees will benefit from standardized prior authorization rules for managed care organizations and new reporting on service denials and approvals.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Mandating 1–3 day turnaround for electronic prior authorizations significantly reduces delays in care, especially for time-sensitive conditions, improving access and reducing patient anxiety and out-of-pocket costs from delayed treatment.
HealthcarePeopleRef: Sec. 2(1)(a)-(b), Sec. 3(1)(a)-(b), Sec. 4(1)(a)-(b)Barring AI from being the *sole* basis for denial ensures that clinical decisions remain in the hands of licensed professionals, reducing algorithmic bias and protecting patients from opaque, automated denials—especially critical for marginalized groups often overrepresented in AI error rates.
HealthcarePeopleRef: Sec. 2(3)(a), Sec. 3(3)(a), Sec. 4(3)(a)Requiring disclosure of reviewer ID, provider NPI, credentials, and specialty in denial notices increases accountability and enables patients and providers to challenge decisions more effectively—particularly helpful for non-English speakers and medically underserved patients.
HealthcarePeopleRef: Sec. 2(1)(e), Sec. 3(1)(e), Sec. 4(1)(e)Mandating annual updates to clinical criteria with explicit inclusion of racial, ethnic, gender, and underserved population considerations helps reduce disparities in coverage decisions and improves equity in access to care.
HealthcarePeopleRef: Sec. 2(1)(d), Sec. 3(1)(d), Sec. 4(1)(d)API mandates and quarterly reporting on prior authorization volumes, denial rates, and AI use create transparency that enables public oversight, regulatory enforcement, and data-driven policy improvements—benefiting providers and patients through system-wide accountability.
HealthcarePeopleRef: Sec. 2(4)(a), Sec. 3(4)(a), Sec. 4(4)(a), Sec. 6
Potential Concerns (5)
Shorter prior authorization timelines (e.g., 1–3 days for electronic requests) may increase administrative burden on health plans, potentially leading to rushed decisions or increased denials to meet deadlines—especially for complex cases—reducing quality of review despite faster turnaround.
HealthcarePeopleRef: Sec. 2(1)(a)-(b), Sec. 3(1)(a)-(b), Sec. 4(1)(a)-(b)Mandated API development and interoperability by 2025/2027 will require significant one-time technology investments from insurers and MCOs, especially smaller plans; these costs may be passed to employers or through higher premiums over time.
Business & EmploymentLean peopleRef: Sec. 2(4)(a)-(b), Sec. 3(4)(a)-(b), Sec. 4(4)(a)-(b)Prohibiting AI as the *sole* basis for denial—but allowing it to *aid* decisions—creates a regulatory gray zone where AI may still unduly influence outcomes if human reviewers defer to algorithmic recommendations, especially in resource-constrained settings.
HealthcareLean peopleRef: Sec. 2(3)(a), Sec. 3(3)(a), Sec. 4(3)(a)Limiting policy changes to once per year (effective Jan. 1) may reduce administrative churn but could delay necessary updates to clinical criteria or coding in response to emerging medical evidence or practice changes.
HealthcareLean peopleRef: Sec. 2(2), Sec. 3(2), Sec. 4(2)Prohibiting retrospective denials for valid prior authorizations is beneficial, but the exception allowing retrospective denials for *non*-emergency care (even if authorized) without appeal rights may create loopholes that insurers exploit to deny payment after care is delivered.
HealthcareRef: Sec. 5
Who Is Most Affected
Patients—especially those with chronic conditions, low income, or limited English proficiency—will benefit most from faster, more transparent, and human-reviewed authorization decisions, reducing delays in care and improving trust in the system.
Providers (doctors, clinics, hospitals) will benefit from reduced administrative burden, clearer denial rationales, and automated tools that streamline prior auth—though they may face initial adaptation costs for API integration.
State employees and retirees will benefit from improved timeliness and transparency in prior authorization, aligning their coverage with best practices now codified for other plans.
Medicaid enrollees—particularly people of color, rural residents, and those with disabilities—will benefit from standardized, equitable review criteria and increased oversight of MCOs, reducing coverage disparities.
Health insurers and MCOs will face increased operational costs and compliance burdens, especially in technology infrastructure and staffing for timely reviews; while large insurers may absorb costs, smaller plans may struggle, potentially consolidating further.